Consequently, we concluded to a mixed etiology severe anemia, initially hypo regenerative due to prolonged PARP inhibitor toxicity, and secondly complicated with an extravascular hemolysis due to warm autoimmune hemolytic anemia (wAIHA). The gene discussed is PARP1; the disease is anemia (phenotype).